Last updated on February 2020

Evaluation of RC28-E Injection in Wet Age-related Macular Degeneration

Brief description of study

This is a non-randomized, open-label, multicenter, 48-week study to investigate the efficacy, safety and pharmacokinetics of RC28-E injection in the treatment of patients with wet age-related macular degeneration by multiple administration.

Clinical Study Identifier: NCT04270669

Find a site near you

Start Over